Baron SMID Cap ETF · NYSE (us_market)
— · — · —
The fund is a diversified fund that, under normal circumstances, invests at least 80% of its net assets in equity securities (including depositary receipts) of small- and mid-sized companies.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-15$25.31 RISE2026-03-30$20.89 PEAK2026-05-29$24.22 134d | -17.5% 74d | Missed | Missed | — | — | +15.9% 60d | Missed |
No scored news yet for a sentiment trend.
Insulet shares fall after the company warns certain Omnipod 5 Pods may under-deliver insulin, linked to reports of serious health events.
The five ETFs bring Baron Capital's growth investing strategy to the ETF market across technology, financials, SMID-cap and global equities.
NEW YORK, December 15, 2025--Baron Capital, the premier New York-based growth equity investment firm, with a 43-year track record of long-term, fundamental, research-driven investing, today launched five Active ETFs: Baron First Principles ETF (NYSE: RONB), Baron Global Durable Advantage ETF (NYSE: BCGD), Baron SMID Cap ETF (NYSE: BCSM), Baron Financials ETF (NASDAQ: BCFN), and Baron Technology ETF (NASDAQ: BCTK). The new Active ETFs expand Baron Capital’s investment offerings, providing direct